Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • fcchau
    Junior Member
    • Feb 2017
    • 1

    #1

    Very large FPKM from cuffdiff that doesn't match read counts

    Hi Everyone,

    I am relatively new to RNAseq, and hope can get some help from more experienced people here.

    So I used cuffdiff to look at differential gene expression. I have 2 conditions and 3 replicates for each condition. When I look at the genes_read_group_tracking file, I found that for some genes, one of the replicates has very large FPKM values that doesn't match raw frags count.

    For example this is what I see:

    tracking_id condition replicate raw_frags internal_scaled_frags external_scaled_frags FPKM effective_length status
    XLOC_009487 WT 0 4 4.21548 4.21548 1150.43 - OK
    XLOC_009487 WT 1 5 5.39083 5.39083 1.14629 - OK
    XLOC_009487 WT 2 8 7.56804 7.56804 1.60234 - OK
    XLOC_009487 OE 1 2 2.29124 2.29124 0.476229 - OK
    XLOC_009487 OE 0 5 4.84785 4.84785 0.995213 - OK
    XLOC_009487 OE 2 5 4.07315 4.07315 0.77989 - OK

    You can see that the FPKM for WT 0 is 1150 where as the raw frags is only 4.2. The other samples are fine. I observed this in multiple genes, and they don't always happen to the same sample. I also check the FPKMs from cufflinks, and they look normal. So seems that it's cuffdiff's problem.

    Does anyone know why this happen and how to solve it? Appreciate the help!
  • fanli
    Senior Member
    • Jul 2014
    • 197

    #2
    I think there is a decent amount of evidence out there that cuffdiff is less than optimal for gene-level DE analysis.

    See:

    Recent advances in next-generation sequencing technology allow high-throughput cDNA sequencing (RNA-Seq) to be widely applied in transcriptomic studies, in particular for detecting differentially expressed genes between groups. Many software packages have been developed for the identification of differentially expressed genes (DEGs) between treatment groups based on RNA-Seq data. However, there is a lack of consensus on how to approach an optimal study design and choice of suitable software for the analysis. In this comparative study we evaluate the performance of three of the most frequently used software tools: Cufflinks-Cuffdiff2, DESeq and edgeR. A number of important parameters of RNA-Seq technology were taken into consideration, including the number of replicates, sequencing depth, and balanced vs. unbalanced sequencing depth within and between groups. We benchmarked results relative to sets of DEGs identified through either quantitative RT-PCR or microarray. We observed that edgeR performs slightly better than DESeq and Cuffdiff2 in terms of the ability to uncover true positives. Overall, DESeq or taking the intersection of DEGs from two or more tools is recommended if the number of false positives is a major concern in the study. In other circumstances, edgeR is slightly preferable for differential expression analysis at the expense of potentially introducing more false positives.

    RNA sequencing (RNAseq) has become the method of choice for transcriptome analysis, yet no consensus exists as to the most appropriate pipeline for its analysis, with current benchmarks suffering important limitations. Here, we address these ...


    If you are only doing DGE, I'd recommend edgeR or DESeq2

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Working...